John Doe
General SurgeonPretium saepe pariatur ornare cillum repudiandae inceptos iaculis cumque vulputate sequi neque quos exercitation aliquip interdum, veniam? Aute error, elit!
From Our Blog
Blog
10,000 severe asthma patients
The International Severe Asthma Registry (ISAR) has massively exceeded its goal of 10,000 severe asthma
ISAR New Website
ISAR is excited to share the refreshed homepage of our website! It now features a
Asthma Week
National Asthma Awareness Week is held each September (1st – 7th) to raise awareness of
The Introduction of Biologics to treat severe asthma
#Asthma may be one of the most common diseases, yet it’s still difficult to manage. The
PREVAIL Trial
The PREVAIL Trial is currently recruiting practices across the West Midland and Yorkshire & Humber
OPRI is excited to share a milestone in asthma phenotype recognition!
OPRI is excited to share a milestone in asthma phenotype recognition! The ISAR #publication titled,
Are severe asthma patients getting the right treatment?
Research has shown that you can’t take a one-size-fits-all approach to severe asthma management due
The double-edged swords that are inhaled corticosteroids in COPD.
The double-edged swords that are inhaled corticosteroids in COPD. Inhaled corticosteroids (ICS) as part of
CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients
Describing the core framework of the Quality Improvement Program, the latest paper from the CONQUEST
Difficult to treat Asthma Australia
Our Difficult-To-Treat Asthma Audit is proving successful in Australia and we are getting great feedback. One
